Gambaran Gejala Pada Pasien COVID-19 Dengan Komorbid, Di RSUD Labuang Baji Makassar
DOI:
https://doi.org/10.47859/jmu.v8i02.203Keywords:
Symptoms Covid_19, ComorbidAbstract
Background: Corona virus disease 2019 is a disease caused by infection with the SARS-CoV-2 virus, which generally attacks the respiratory system in humans, Corona Virus disease can cause different symptoms, be it mild, moderate to severe symptoms. The level of symptoms in Corona Virus disease patients is influenced by various factors, both internal and external, and one of the influencing factors is the presence of comorbidities or comorbidities. The purpose of this study was to find out the description of symptoms in Corona Virus disease patients with comorbidities at Labuang Baji Hospital, Makassar City Method The research design used is descriptive analytic through a cross-sectional approach. The total population in this study was 129 people. The sampling technique used was total sampling.. Results: In this study, the results showed that of 129 Corona virus disease patients, most of them had comorbid cardiovascular disorders (hypertensive heart disease) and of all patients who had comorbidities, most of the respondents (48.1%) experienced severe symptoms. Conclusion: From this study it can be concluded that patients who have comorbid cardiovascular disease are more likely to experience severe symptoms when exposed to the corona virus.
References
Cen, Y; Chen, X; Shen, Y; Zhang, XH; Lei, Y; Xu, C; Jiang, WR; Xu, HT; Chen, Y; Zhu, J; Zhang, LL, Liu, YH. 2020. Risk Factors for disease progression in patients with mild to moderate Coronavirus disease 2019 a multi centre observational. Clinical Microbiology and Infection.www.clinicalmicrobiologya ndinfectionDinkes Provinsi Sulawesi Selatan. (2021). Data Perkembangan COVID-19 Di Sulawesi Selatan 26 Januari 2021.
Herick, W. (2020). Dampak Corona Virus Terhadap Sistema Cardiovaskular.
Hidayani,Wuri Ratna (20200. Faktor-Faktor Risiko yang berhubungan dengan Covid-19, literatur Review, Jurnal Untuk Masyarakat Sehat, 120-134
Kemenkes RI. (2020). Pedoman Kesiapsiagaan Menghadapi Corona Virus Disease (COVID-19). Jakarta Selatan.
Kementrian Kesehatan RI. (2021). Perkembangan Corona Virus Disease (COVID-19)
Li B, Yang J, Zhao F, et al. Prevalence and Impact of cardiovasculer metabolic diseases on COVID 19 in China Clin Res Cardiol.E pub ahead of Print 11 March 2020. DOI: 10.1007/s00392-020-01626-9
Matla, S., & Nurwaty, N. (2020). Analisis Pengaruh Tingkat Kematian Akibat COVID-19 Terhadap Kesehatan Mental Masyarakat Indonesia.
Pada, K., Yang, P., Di, B., Sakit, R., Pusat, U., Manado, D. K., … Ratulangi, S. (2018). Hubungan Antara Hipertensi Dengan Kejadian Penyakit Jantung Koroner. Kesmas, 7(4).
Perhimpunan Dokter Paru Indonesia. (2020). Pneumonia COVID-19. Jakarta.
Putra, Y. A., Udiyono, A., & Yuliawati, S. (2018). Gambaran Tingkat Kecemasan Dan Derajat Serangan Asma Pada Penderita Dewasa Asma Bronkial. Jurnal Kesehatan Masyarakat, 6, 357–364.
Samuel, I., & Riyanto, B. (2021). Anosmia pada COVID-19, 48 no 1, 25.
Setiawan, D., Putri, R. N., & Suryanita, R. (2019). Debi Setiawan, 2) Ramalia Noratama Putri, 3) Reni Suryanita, 4(1), 8–19.
Susilo, A., Rumende, C. M., Pitoyo, C. W., Santoso, W. D., Yulianti, M., Herikurniawan, H., … Yunihastuti, E. (2020). Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia, 7(1), 45.
Suwaryo, P. A. W., Kupitasari, M. D., & Setianingsih, E. (2020). Kontrol Asma Menggunakan Latihan Breathing Retraining. University Research Colloquium, 58–63.
Tignanelli CJ, Ingraham NE, Sparks MA, et al. Antihypertensive drugs and Risk of COVID 19.Lancet Respir Med.2020; 8(5):e30-e31. Doi:10.106/S2213-2600(20)30153-3
Wahyuni, S. (2018). Peran Imunitas Humoral Pada Penyakit Systemic Lupus Erythematosus (Sle). AVERROUS: Jurnal Kedokteran Dan Kesehatan Malikussaleh, 3(1), 88.
Wang , D; Yin, Y; Hu, Chang; Liu, Xing; Zhang, X; Zhou, S; Jian, M; Xu, H; Prowle, J; Hu, B; Li, Y; Peng, Z. 2020. Clinical Course and Outcome of 107 patient infected with the Novel Coronavirus , SARS-CoV-2, discharged from two hospital in Wuhan, China. BMC.(2020)24:188, p: 1-9
Wang, D; Hu, B; Hu, C; Zhu, F; Liu, X; Zhang, J, et al. 2020. Clinical Characteristics of 138 Hospitapized Patients with 2019 Novel CoronaVIRUS-Infected Pneumonia in Wuhan, China.JAMA.Original Investigation. 2020;323(11):1061- 1069
WHO. (2020). Coronavirus disease (COVID 19) pandemic.https://who.int. diakses tanggal 20 September 2020.
Wijaya, E. (2018). Hubungan Umur, Jenis Kelamin, dan Obesitas Terhadap Sistem Cardiovaskular.
World Health Organization. (2020). Q&A on coronaviruses (COVID-19)”, https://www.who.int/indonesia/new s/novel-coronavirus/qa-for-public.
Yang J, Zheng Y, Gou X, Pu K, C. Z., & Guo Q, Ji R, Wang H, W. Y. and Z. Y. (2020). Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta- analysis. International journal of infectious diseases.
Yudhawaty, R., & Krisdanti, D. P. A. (2017). Imunopatogenesis Asma. Respirasi, 3 no 1, 27–33.
